EPISODE · May 2, 2026 · 31 MIN
Can semaglutide be used to treat alcohol use disorder?
from The Lancet in conversation with · host The Lancet Group
The Lancet’s Niall Boyce and Jonathan Pimm, and eBioMedicine’s Kalypso Karastergiou discuss an exciting new potential treatment for alcohol use disorder: semaglutide. As new research is published in The Lancet, they go behind the headlines with lead author Professor Anders Fink-Jensen to ask what the study showed, and what its implications are for the future of addiction medicine. Click here to read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3/fulltext
What this episode covers
The Lancet’s Niall Boyce and Jonathan Pimm, and eBioMedicine’s Kalypso Karastergiou discuss an exciting new potential treatment for alcohol use disorder: semaglutide. As new research is published in The Lancet, they go behind the headlines with lead author Professor Anders Fink-Jensen to ask what the study showed, and what its implications are for the future of addiction medicine. Click here to read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3/fulltext
NOW PLAYING
Can semaglutide be used to treat alcohol use disorder?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m